Metraipolis › archive › dc_ff099c46770b
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas — Europe PMC PMID:40992926
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40992926
- DOI
- 10.26508/lsa.202503359
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:05:35.604Z
- SHA-256 of the archived text
7964ae66a197a0e0f8488863dd6862692624dcba2cdbb578bd77f86b7600edca- Stable URL of this page
https://metraipolis.com/documento/dc_ff099c46770b
How to cite
Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas — Europe PMC PMID:40992926 — Europe PMC (en), https://europepmc.org/article/MED/40992926 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff099c46770b (Metraipolis archive dc_ff099c46770b, sha256 7964ae66a197a0e0f8488863dd6862692624dcba2cdbb578bd77f86b7600edca)
BibTeX
@misc{dcff099c46770b,
title = {Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas — Europe PMC PMID:40992926},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40992926},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff099c46770b; sha256 7964ae66a197a0e0f8488863dd6862692624dcba2cdbb578bd77f86b7600edca},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40992926. Agents can read the archived copy with the MCP tool read_document.